SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION

性激素对泪腺分泌的调节

基本信息

  • 批准号:
    3266838
  • 负责人:
  • 金额:
    $ 8.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-09-30 至 1994-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from applicant's abstract): Dry eye disease is one of the most frequently encountered categories of ocular morbidity, and insufficient lacrimal gland fluid production is a frequent source of the problem. Lacrimal insufficiency results from autoimmune disease, most notably Sjogren's syndrome, and from other, poorly-understood etiologies. Most dry eye patients, and the vast majority of Sjogren's syndrome patients, are postmenopausal women. Additionally, many women who are pregnant or are taking oral contraceptives are unable to wear contact lenses due to decreased aqueous tear production. Thus, it appears that reproductive hormones modulate lacrimal secretory function and susceptibility to autoimmune disease. The goal of this study is to determine the hormonal factors regulating the secretory status of the female lacrimal gland. The specific aims are to test three hypotheses concerning interactions between androgens, estrogens, and prolactin: 1. Decreasing androgen and increasing estrogen levels result in lacrimal insufficiency. Because androgens as well as estrogens are lost after menopause, and because increasing estrogen levels decrease free androgens by increasing synthesis of sex hormone binding globulin, this hypothesis can account for the observation that lacrimal function is impaired both post-menopausally and in high-estrogen states. 2. Prolactin at optimal levels acts synergistically with androgens and estrogens in maintaining normal lacrimal gland function, while either insufficient or excess prolactin impairs function. 3. Prolactin synthesis in the lacrimal gland is decreased by androgens and circulating prolactin, and it is increased by estrogens. This hypothesis, to be tested with materials from the first two specific aims, is of interest because of the possibility that prolactin might act as an intracrine, or if released into the interstitium, an autocrine or paracrine mediator of lacrimal epithelial or lymphocytic activity. Rabbits will be ovariectomized, then treated with androgens, with and without estrogens, to test the first hypothesis. They will be treated with bromocriptine, prolactin, and sex steroids to test the second. Total membrane-associated Na,K-ATPase, muscarinic receptors, and beta-adrenergic receptors will be measured in initial surveys. The subcellular organization of these parameters, plus Na/H antiport, will be determined in final experiments, as will resting and cholinergically stimulated lacrimal gland fluid flow rates, lacrimal immunohistopathology, and acinar morphology. Prolactin mRNA abundance and immunoreactivity will be measured to test the third hypothesis. If the specific hypotheses are proven correct, the experimental results should inspire design of strategies for preventing or reversing hormonally-mediated lacrimal insufficiency.
描述(改编自申请人的摘要):干眼病是一种 最常见的眼部疾病类别,以及 泪腺液产生不足是 问题. 泪腺功能不全是由自身免疫性疾病引起的, 尤其是干燥综合征,以及其他病因学知之甚少。 大多数干眼症患者和绝大多数干燥综合征患者 患者为绝经后妇女。 此外,许多女性 怀孕或正在服用口服避孕药者不能戴隐形眼镜 晶状体由于减少水泪液的产生。 因此,似乎 生殖激素调节泪液分泌功能, 自身免疫性疾病的易感性。 本研究的目的是 确定调节分泌状态的激素因素, 女性泪腺 具体目的是检验三个假设 关于雄激素、雌激素和催乳素之间的相互作用:1. 雄激素减少和雌激素水平增加会导致泪腺炎 不足。 因为雄激素和雌激素都会丢失 更年期,因为增加雌激素水平减少游离雄激素 通过增加性激素结合球蛋白的合成, 可以解释泪腺功能受损的观察结果, 绝经后和高雌激素状态。 2. 最佳催乳素 水平与雄激素和雌激素协同作用, 正常的泪腺功能,而无论是不足或过剩 催乳素损害功能。 3. 催乳素在泪腺中的合成 雄激素和循环催乳素降低, 雌激素类。 这一假设,将用前两个材料进行测试, 具体的目的,是感兴趣的,因为催乳素的可能性, 可能作为一种内分泌,或者如果释放到氚中, 泪腺上皮或淋巴细胞的自分泌或旁分泌介质 活动 兔子将被切除卵巢,然后用雄激素治疗, 有没有雌激素,来检验第一个假设 他们将 用溴隐亭催乳素和性类固醇来测试第二种 总膜相关Na,K-ATP酶,毒蕈碱受体,和 将在初步调查中测量β-肾上腺素能受体。 的 这些参数的亚细胞组织,加上Na/H反向转运,将是 在最后的实验中确定,休息和胆碱能 刺激泪腺液流速,泪腺免疫组织病理学, 和腺泡形态。 催乳素mRNA丰度和免疫反应性将 来检验第三个假设。 如果具体的假设是 被证明是正确的,实验结果应该启发设计 预防或逆转尿道介导的泪腺炎的策略 不足。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DWIGHT W WARREN其他文献

DWIGHT W WARREN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DWIGHT W WARREN', 18)}}的其他基金

SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION
性激素对泪腺分泌的调节
  • 批准号:
    2019799
  • 财政年份:
    1994
  • 资助金额:
    $ 8.15万
  • 项目类别:
SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION
性激素对泪腺分泌的调节
  • 批准号:
    2163031
  • 财政年份:
    1994
  • 资助金额:
    $ 8.15万
  • 项目类别:
SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION
性激素对泪腺分泌的调节
  • 批准号:
    2163032
  • 财政年份:
    1994
  • 资助金额:
    $ 8.15万
  • 项目类别:
SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION
性激素对泪腺分泌的调节
  • 批准号:
    2711066
  • 财政年份:
    1994
  • 资助金额:
    $ 8.15万
  • 项目类别:
SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION
性激素对泪腺分泌的调节
  • 批准号:
    2545860
  • 财政年份:
    1994
  • 资助金额:
    $ 8.15万
  • 项目类别:
SEX HORMONE REGULATION OF LACRIMAL GLAND SECRETION
性激素对泪腺分泌的调节
  • 批准号:
    3509755
  • 财政年份:
    1992
  • 资助金额:
    $ 8.15万
  • 项目类别:
ENDOCRINOLOGY OF THE TESTIS--FETAL AND NEONATAL ASPECTS
睾丸内分泌学——胎儿和新生儿方面
  • 批准号:
    3313366
  • 财政年份:
    1982
  • 资助金额:
    $ 8.15万
  • 项目类别:
ENDOCRINOLOGY OF THE TESTIS--FETAL AND NEONATAL ASPECTS
睾丸内分泌学——胎儿和新生儿方面
  • 批准号:
    3313365
  • 财政年份:
    1982
  • 资助金额:
    $ 8.15万
  • 项目类别:
ENDOCRINOLOGY OF THE TESTIS--FETAL AND NEONATAL ASPECTS
睾丸内分泌学——胎儿和新生儿方面
  • 批准号:
    3313362
  • 财政年份:
    1982
  • 资助金额:
    $ 8.15万
  • 项目类别:

相似海外基金

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
  • 批准号:
    10930196
  • 财政年份:
    2023
  • 资助金额:
    $ 8.15万
  • 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
  • 批准号:
    10735807
  • 财政年份:
    2023
  • 资助金额:
    $ 8.15万
  • 项目类别:
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
  • 批准号:
    10418461
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
  • 批准号:
    RGPIN-2019-04999
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
    Discovery Grants Program - Individual
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10570208
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10688086
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10355174
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
  • 批准号:
    10431620
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
  • 批准号:
    2744296
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
    Studentship
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10525097
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了